With an AAALAC-accredited vivarium housing a large number of rodents and large animals, PharmaLegacy provides a wide range of animal models for diseases such as autoimmune diseases, inflammation, oncology, bone metabolism, orthopaedics, liver/lung diseases, and metabolic diseases. They also offer in vivo studies in different species, including non-human primates. In addition to their animal models, PharmaLegacy provides services for PK/PD/ADME studies, molecular pharmacology, and preliminary toxicology assessment. They claim to be the only Chinese CRO capable of offering in-vivo efficacy studies for bone and orthopaedics related drugs and devices. Overall, PharmaLegacy aims to assist pharmaceutical companies in obtaining a variety of research services to support the development of small and large molecule therapeutics.